BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34494505)

  • 1. New insight into the mechanism of granulocyte colony-stimulating factor (G-CSF) that induces the mobilization of neutrophils.
    Theyab A; Algahtani M; Alsharif KF; Hawsawi YM; Alghamdi A; Alghamdi A; Akinwale J
    Hematology; 2021 Dec; 26(1):628-636. PubMed ID: 34494505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent.
    Bendall LJ; Bradstock KF
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):355-67. PubMed ID: 25131807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium in the treatment of neutropenia.
    Petrini M; Azzarà A
    Curr Opin Hematol; 2012 Jan; 19(1):52-7. PubMed ID: 22123660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF-induced hematopoietic stem cell mobilization from the embryonic hematopoietic niche does not require neutrophils and macrophages.
    Kim JW; Fedorov EA; Zon LI
    Exp Hematol; 2024 Mar; 131():104147. PubMed ID: 38160994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF.
    Liu F; Poursine-Laurent J; Link DC
    Blood; 2000 May; 95(10):3025-31. PubMed ID: 10807765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells.
    Herbert KE; Walkley CR; Winkler IG; Hendy J; Olsen GH; Yuan YD; Chandraratna RA; Prince HM; Lévesque JP; Purton LE
    Transplantation; 2007 Feb; 83(4):375-84. PubMed ID: 17318068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.
    Martino M; Recchia AG; Moscato T; Fedele R; Neri S; Gentile M; Alati C; Vincelli ID; Piro E; Penna G; Musolino C; Ronco F; Molica S; Morabito F
    Cytotherapy; 2015 Oct; 17(10):1485-93. PubMed ID: 26188967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD
    Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic recovery in patients who are treated with autologous stem cells transplantation taken from bone marrow after granulocyte-colony-stimulating factor stimulation.
    Gawronski K; Rzepecki P; Oborska S; Wasko-Grabowska A
    Transplant Proc; 2011 Oct; 43(8):3114-5. PubMed ID: 21996240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta.
    King AG; Horowitz D; Dillon SB; Levin R; Farese AM; MacVittie TJ; Pelus LM
    Blood; 2001 Mar; 97(6):1534-42. PubMed ID: 11238087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation.
    Tabbara IA; Ghazal CD; Ghazal HH
    Cancer Invest; 1997; 15(4):353-7. PubMed ID: 9246158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide plus granulocyte-colony stimulating factor for hematopoietic stem cell mobilization in patients with multiple myeloma.
    Lin TL; Wang PN; Kuo MC; Hung YH; Chang H; Tang TC
    J Clin Apher; 2016 Oct; 31(5):423-8. PubMed ID: 26340986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation.
    Shimazaki C; Oku N; Uchiyama H; Yamagata N; Tatsumi T; Hirata T; Ashihara E; Okawa K; Goto H; Inaba T
    Bone Marrow Transplant; 1994 Mar; 13(3):271-5. PubMed ID: 7515300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of peripheral blood stem cells by granulocyte-colony stimulating factors: comparison of a standard dose of glycosylated and mutated granulocyte-colony stimulating factor in non-Hodgkin's lymphoma patients following CHOP therapy.
    Takemoto Y; Wada H; Takatsuka H; Okamoto T; Kakishita E
    Drugs Exp Clin Res; 2000; 26(1):1-5. PubMed ID: 10761530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors.
    Aprikyan AA; Liles WC; Park JR; Jonas M; Chi EY; Dale DC
    Blood; 2000 Jan; 95(1):320-7. PubMed ID: 10607719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of granulocyte colony stimulating factor on neutrophil functions in children with neutropenia after chemotherapy in the course of neoplasma.
    Czygier M; Dakowicz Ł; Szmitkowski M
    Adv Med Sci; 2007; 52():143-6. PubMed ID: 18217407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.